Chronic Plaque Psoriasis Completed Phase 2 Trials for Calcitriol (DB00136)

IndicationStatusPhase
DBCOND0033442 (Chronic Plaque Psoriasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00419666A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque PsoriasisTreatment